Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humanigen, Inc. - Common Stock (NQ:HGEN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Humanigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK) stock increased by 12.65% to $9.26 during Tuesday's pre-market session. The company's market cap stands at $434.5... 
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 43.5% to $11.21 in pre-market trading. Vertex Energy, shares jumped around 96% on Friday on continued momentum after the company... 
Via Benzinga
44 Biggest Movers From Friday
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares jumped 95.7% to close at $7.81 on continued momentum after the company announced it will acquire an Alabama refinery and related... 
Via Benzinga
38 Stocks Moving In Friday's Mid-Day Session
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 48.6% to $5.93 on continued momentum after the company announced it will acquire an Alabama refinery and related... 
Via Benzinga
Humanigen Files US Emergency Use Application For Lenzilumab For COVID-19
Humanigen Inc (NASDAQ: HGEN) has submitted an application to the FDA seeking Emergency Use Authorization (EUA) for lenzilumab to treat patients hospitalized with... 
Via Benzinga
Exposures Product Safety
Humanigen Recruits Chime Biologics As Manufacturing Partner For Lenzilumab
Humanigen Inc (NASDAQ: HGEN) and Chime Biologics, contract development and manufacturing organization (CDMO), have entered into a manufacturing services... 
Via Benzinga
Humanigen Shares Gain On FDA Emergency Filing Plans For COVID-19 Drug By June
Humanigen Inc (NASDAQ: HGEN) is prepping its COVID-19 drug lenzilumab for an emergency use authorization with the FDA before the month’s end. According to its... 
Via Benzinga
Exposures COVID-19 Product Safety
74 Biggest Movers From Friday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:... 
Via Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week... 
Via Benzinga
Review Of Present Therapies For Covid-19
A summary of authorized drugs for Covid-19, those in development, and those that have failed. 
Via Talk Markets
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021
Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from... 
Via Benzinga
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The... 
Via Benzinga
Why Humanigen Stock Vaulted Higher Today
Detailed results from a late-stage study of the company's lead candidate were published online. 
Via The Motley Fool
Exposures COVID-19
52 Biggest Movers From Yesterday
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)... 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64.... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Estée Lauder Reports Mixed Q3 Results
Following the market opening Monday, the Dow traded up 0.80% to 34,147.27 while the NASDAQ rose 0.54% to 14,038.00. The S&P also rose, gaining 0.65% to 4,208.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Popular Reddit Biotech Stocks That You Should Avoid
We think speculative Reddit biotech stocks Ocugen, Inc. (OCGN), Humanigen Inc. (HGEN), and 180 Life Sciences Corp. (ATNF) should be avoided at all costs given questions about their prospects or ability... 
Via Talk Markets
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
Humanigen's Lenzilumab Shows Encouraging Response Rate In Blood Cancer Study
Humanigen Inc (NASDAQ: HGEN) has announced data from the Phase 1b portion of the ZUMA-19 trial evaluating its lead candidate lenzilumab in patients... 
Via Benzinga
Cramer Weighs In On Paysafe, Xilinx And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (... 
Via Benzinga
Could These 2 Exciting COVID Stocks be 10-Baggers?
They're approaching the treatment-race finish line. 
Via The Motley Fool
Exposures COVID-19
Humanigen's Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer Study
Humanigen Inc (NASDAQ: HGEN) has announced results from the Phase 1 trial evaluating its second Humaneered antibody, ifabotuzumab, in patients with... 
Via Benzinga
30 Stocks Moving in Friday's Pre-Market Session
Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and... 
Via Benzinga
Could Humanigen Stock Soar Even Higher After Its COVID Antibody Results?
It's a definite maybe. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.